# Safety and Efficacy Study of PEA and Polydatin on Intestinal Inflammation and Visceral Hyperalgesia in IBS Patients

> **NCT01370720** · PHASE2 · UNKNOWN · sponsor: **MARIA CRISTINA COMELLI** · enrollment: 60 (estimated)

## Conditions studied

- Irritable Bowel Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** Recoclix
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01370720
- **Lead sponsor:** MARIA CRISTINA COMELLI
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-02
- **Primary completion:** 2012-12
- **Final completion:** 2013-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2012-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01370720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01370720, "Safety and Efficacy Study of PEA and Polydatin on Intestinal Inflammation and Visceral Hyperalgesia in IBS Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01370720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*